Navigation Links
Beckman Coulter Investor Events Second Half of 2008
Date:9/10/2008

ORANGE COUNTY, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

-- Q3 2008 Earnings Release scheduled for Tuesday, October 28, 2008. Q3

conference call scheduled for 5:00 p.m. ET.

-- Clinical Lab Tour: Investor Event scheduled for Thursday,

September 25, 2008, in Indianapolis, Indiana. For more information,

contact Beckman Coulter's Investor Relations Department at

(714) 773-7620.

-- Beckman Coulter 2008 Annual Business Review. The executive management

of the company will host one event in New York City, New York, on

Tuesday, December 16, 2008:

-- There will be a live webcast of this event. It will be accessible

through Beckman Coulter's website.

-- The company will attend the following conference:

-- Oppenheimer 19th Annual Healthcare Conference -- Tuesday,

November 4, 2008, in New York City, New York.

-- Lazard Capital Markets Healthcare Conference -- Tuesday,

November 18, 2008, New York City, New York.

-- Piper Jaffray Conference -- Tuesday, December 2, 2008, New York

City, New York.

-- RBC Conference -- Thursday, December 11, 2008, New York City, New

York.

Please refer to the company's website at http://www.beckmancoulter.com for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Contact: Cynthia Skoglund, (714) 773-8213

Manager, Investor Relations


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
2. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
3. Beckman Coulter Announces Second Quarter 2008 Results
4. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
5. Upcoming Beckman Coulter Investor Events Second Half of 2008
6. Beckman Coulter to Present at Upcoming Healthcare Conferences
7. Beckman Coulter Announces First Quarter 2008 Results
8. Beckman Coulter Acquires Rights to Hepatitis C Virus
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
11. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... That Will Drive Precision Farming in 2017 and Beyond. The paper outlines the ... in the precision ag industry. , “We’ve witnessed a lot of highs and ...
(Date:5/23/2016)... BOSTON and LONDON , May 23, ... 10 Could See Frontage Boost Efficiency by 40% - ... - Frontage Enforce Quality, Compliance and Traceability Within the ... (CRO) with labs in the United States ... 10 to be deployed across its laboratory facilities. In addition ...
(Date:5/22/2016)... ... 22, 2016 , ... Doctors in Rome say micronutrients found in certain foods ... Surviving Mesothelioma has just posted an article on the new research. Click here ... Clinical Sciences and Translational Medicine evaluated more than 150 studies on polyphenols in cancer ...
(Date:5/20/2016)... ... 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural cell ... treat the disease. Surviving Mesothelioma has just posted an article on the new study. ... based their mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/21/2016)... , March 22, 2016 ... recognition with passcodes for superior security   ... a leading provider of secure digital communications services, today ... biometric technology and offer enterprise customers, particularly those in ... facial recognition and voice authentication within a mobile app, ...
(Date:3/15/2016)... 15, 2016 --> ... Transparency Market Research "Digital Door Lock Systems Market - Global ... 2023," the global digital door lock systems market in terms ... and is forecast to grow at a CAGR of 31.8% ... and medium enterprises (MSMEs) across the world and high industrial ...
Breaking Biology News(10 mins):